VIO-01

News alerts, weekly reports and conference planners

Company:

Valerio Therap

Drug class:

PARP1 inhibitor, KU70/KU80 inhibitor, MRN complex inhibitor

Related drugs:

HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	VIO-01 Sensitive: D – Preclinical VIO-01 Sensitive : D	VIO-01 Sensitive: D – Preclinical VIO-01 Sensitive : D
BRCA1 mutation	Breast Cancer	BRCA1 mutation	Breast Cancer	olaparib + VIO-01 Sensitive: D – Preclinical olaparib + VIO-01 Sensitive : D	olaparib + VIO-01 Sensitive: D – Preclinical olaparib + VIO-01 Sensitive : D
HRD	Solid Tumor	HRD	Solid Tumor	VIO-01 Sensitive: D – Preclinical VIO-01 Sensitive : D	VIO-01 Sensitive: D – Preclinical VIO-01 Sensitive : D

Associations
(3)